Farms.com Home   News

Can You Take Me Higher

Creed’s song Higher, with its chorus “can you take me higher,” came to mind when learning of the latest increase in farmland values from the Federal Reserve Bank of Kansas City. Despite many headwinds, farmland values continue to answer Creed’s question with an emphatic “yes”. The latest evidence comes from a survey of commercial bankers by the Kansas City Federal Reserve Bank. Bank economists Cortney Cowley, Jannety Mosely, and Ty Kreitman report bankers in the Tenth District (Nebraska, western Missouri, Kansas, Oklahoma, Colorado, Wyoming, and northern New Mexico) indicated the value for non-irrigated land rose 11 percent in the fourth quarter of 2023 compared to 2022. Values on irrigated and pasture ground exceeded 2022 levels by 7 percent. The increases on non-irrigated and irrigated land in Nebraska were the highest in the district, up 15 percent and 9 percent, respectively. Pasture ground in Nebraska was up 3 percent. 

The growth in land values came despite lower commodity prices, higher interest rates, and reports of financial strain among producers.

Click here to see more...

Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.